97 results
Page 4 of 5
424B5
b8utnw2
10 Aug 18
Prospectus supplement for primary offering
9:04am
424B5
vkv4inh7d8 n7a
9 Aug 18
Prospectus supplement for primary offering
6:58am
6-K
EX-99.1
kmdnvih
14 May 18
RedHill Biopharma to Host Investor Webcast on RHB-104 for Crohn’s Disease on May 15
8:00am
424B5
v88n2 fifru3ggn02
23 Dec 16
Prospectus supplement for primary offering
12:00am
424B5
5ti opsaqytpsrifx0r
23 Dec 16
Prospectus supplement for primary offering
12:00am
6-K
EX-1.1
vivw s6uy
23 Dec 16
Current report (foreign)
12:00am
6-K
EX-99.1
6ropto
6 Oct 16
RedHill Biopharma Provides Progress Update on RHB-104 Phase III Crohn’s Disease Program and Introduces Option for Early Stop for Success in Q2/2017
12:00am
6-K
EX-99
rpwxjl7rrq8 cr2qvdaa
9 Sep 15
Form 6-K Filing Document
12:00am
6-K
EX-1.1
1vhmp
21 Jul 15
Current report (foreign)
12:00am
6-K
EX-1.1
bfe9w
13 Feb 15
Current report (foreign)
12:00am
424B5
xgfo3l ipzgq
10 Feb 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
lc4b8ac
9 Feb 15
Current report (foreign)
12:00am
424B5
m2on0ry1b4bz bgo2
9 Feb 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99
f6vy610hh
25 Nov 13
Form 6-K Filing Document
12:00am